Johnson & Johnson
http://www.jnj.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Johnson & Johnson
Darzalex, Medicare Negotiation And The Strategic Importance Of Combination Products
Second generation combination products may become more appealing as companies navigate the complexities of the Medicare price negotiation program.
AbbVie’s Ex-Humira Immunology Business Is Booming
The company raised 2024 revenue expectations, driven by the second quarter performance of its Humira successors Skyrizi and Rinvoq.
Decoding Regulatory Agency Decisions: The Case of Amylyx’s Relyvrio/Albrioza in the US and EU
Relyvrio/Albrioza, Amylyx’s ill-fated treatment for amyotrophic lateral sclerosis, was approved for marketing by the US Food and Drug Administration but rejected by the European Medicines Agency. The Pink Sheet explores how the two agencies applied the available regulatory flexibilities and the impact of other factors, such as regulatory precedence and patient influence, on decision-making.
All Over For Asarina With No Partner Found For Tourette's Drug
Sepranolone may have progressed positively through a Phase IIa trial but its potential to reduce tics has failed to tempt any of the 20 or so potential partners that the Swedish biotech spoke to about a licensing deal.
Company Information
- Industry
- In Vitro Diagnostics
- Medical Devices
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Abiomed, Inc.
- Acclarent Inc.
- Actelion Pharmaceuticals Ltd.
- AdvanceCOR GmbH
- ALZA Corporation
- Alios BioPharma, Inc.
- Animas Corporation
- Aragon Pharmaceuticals, Inc.
- Auris Health, Inc.
- Auris Surgical Robotics
- BeneVir Biopharm, Inc.
- BioMedical Enterprises, Inc.
- Biosense Webster, Inc.
- Calibra Medical, Inc.
- Centyrex Internal Venture
- Cilag AG
- Cerenovus
- Codman & Shurtleff, Inc
- Coherex Medical, Inc.
- Conor Medsystems, Inc.
- Cordis Webster, Inc.
- CorImmun GmbH
- Cougar Biotechnology, Inc.
- Covagen AG
- Crucell N.V.
- DePuy Mitek, Inc.
- DePuy Orthopaedics, Inc.
- DePuy Synthes, Inc.
- Ensure Medical
- Ethicon, Inc.
- FemRx Inc.
- Flexible Stenting Solutions, Inc.
- Gynecare, Inc.
- Hansen Medical, Inc.
- Innovative Surgical Solutions, LLC
- Interventional Spine, Inc.
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Janssen Diagnostics
- Janssen Pharmaceuticals
- Janssen Vaccines & Prevention B.V.
- JointPoint, Inc.
- LifeScan, Inc.
- Medical Enterprises Distribution, LLC
- Medos International SARL
- Megadyne Medical Products, Inc.
- Mentor Corporation
- Micrus Endovascular Corporation
- Molsaic Internal Venture
- Momenta Pharmaceuticals, Inc.
- NeoStrata Company, Inc.
- Neuravi Limited
- NeuWave Medical, Inc.
- Novira Therapeutics
- Omrix Biopharmaceuticals, Inc.
- Ortho Biotech Products, L.P.
- Ortho-McNeil, Inc.
- Orthotaxy
- Peninsula Pharmaceuticals, Inc.
- Pulsar Vascular Inc
- RespiVert Ltd.
- Scios, Inc.
- Selected Nerve Stimulation Internal Ventures
- Sentio, LLC
- Sequus Pharmaceuticals
- Stem Cell Internal Venture
- Synthes, Inc.
- Tibotec
- Torax Medical, Inc.
- Triage Medical, Inc.
- Verb Surgical Inc.
- Veridex
- Vigor Sub, Inc.
- Vistakon
- XO1 Limited
- TARIS Biomedical LLC
- Verb Surgical, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice